Nurix Therapeutics, Inc. ($NRIX)
Hansen Gwenn โ Chief Scientific Officer
Shares
31,333
Price
$0.00
Total Value
$0.00
Nearby Earnings
Jan 27, 2026
EPS:Est: -0.84
Revenue:Est: $13.41M
Jan 28, 2026
EPS:-0.82 (est: -0.84)-2.4%
Revenue:$13.58M (est: $15.60M)-13.0%
Transaction Details
| Insider | Hansen Gwenn |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 3, 2026 |
| Expiration Date | Feb 10, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Employee Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 3, 2026 |
| Shares Purchased | 31,333 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Derivative | Derivative |
| Accession Number | 0001817160-26-000004 |
| Document | View SEC Filing |